News | February 24, 2012

CardioInsight Completes First Commercial Product Installation of its ECVUE Cardiac Mapping System

The ECVUE System provides detailed images of the heart

February 24, 2012 — CardioInsight Technologies Inc. announced that it has successfully completed the European commercial introduction of its ECVUE system to aid in the diagnosis of cardiac arrhythmias. St. Mary's Hospital in London became the company's first commercial customer.  Doctors Prapa Kanagaratnam, Wyn Davies, Nick Peters, David Lefroy, Boon Lim and Shahnaz Jamil-Copley demonstrated the system's effectiveness in a day-to-day clinical setting, completing five clinical cases during its first week of clinical use.

"We are excited to be CardioInsight's first commercial partner and I was very impressed with the ECVUE system's unique ability to display global cardiac activation without the need for an invasive study," said Dr. Prapa Kanagaratnam, the clinical lead for cardiac electrophysiology at St. Mary's Hospital, Imperial College Healthcare. "I think there is a real potential that this could be a disruptive technology that produces a paradigm shift in our approach to managing patients with cardiac arrhythmias."

St. Mary's Hospital has long been recognized as a leading institution in the study of cardiac electrophysiology, dating back to the first systematic clinical use of electrical recordings of the heart's activity in the early 1900's.  Dr. Davies and his team later became a pioneering center for catheter-based 3D mapping.

"We are proud to have the opportunity to work with the world-class team from St. Mary's Hospital as we look to demonstrate the clinical impact of the ECVUE system," said Steve Arless, CEO of CardioInsight.  "I believe their commitment to help pioneer our non-invasive mapping system is a testament to the ECVUE system's clinical potential, and we look forward to further demonstrating this potential under their guidance."

The commercial installation at St. Mary's Hospital is the first of a focused commercial introduction of the ECVUE system in Europe to demonstrate the unique ability to simplify cardiac mapping procedures, reduce procedure time, and expand the use of mapping to new applications.

For more information: www.cardioinsight.com

Related Content

Videos | EP Mapping and Imaging Systems

An example of the Acutus Medical AcQMap High Resolution Imaging and Mapping System to guide electrophysiology (EP) ...

Home October 14, 2021
Home
News | EP Mapping and Imaging Systems

September 29, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the second-generation of ...

Home September 29, 2020
Home
News | EP Mapping and Imaging Systems

September 14, 2020 — Philips Healthcare released new imaging and workflow enhancements for its novel Kodex-EPD cardiac ...

Home September 14, 2020
Home
News | EP Mapping and Imaging Systems

August 17, 2020 — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first electrophyiologist in ...

Home August 17, 2020
Home
News | EP Mapping and Imaging Systems

October 15, 2019 — Kardium Inc. announced that the Globe mapping and ablation system has successfully demonstrated ...

Home October 15, 2019
Home
News | EP Mapping and Imaging Systems

October 9, 2019 — Acutus Medical and Innovative Health announced a partnership that will offer advanced ...

Home October 09, 2019
Home
News | EP Mapping and Imaging Systems

August 19, 2019 — Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper ...

Home August 19, 2019
Home
News | EP Mapping and Imaging Systems

July 15, 2019 — Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and ...

Home July 15, 2019
Home
News | EP Mapping and Imaging Systems

July 5, 2019 — Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug ...

Home July 05, 2019
Home
Technology | EP Mapping and Imaging Systems

July 1, 2019 — Catheter Precision Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its new ...

Home July 01, 2019
Home
Subscribe Now